149 related articles for article (PubMed ID: 2513454)
1. Pathophysiology of polycystic ovary syndrome.
Mauvais-Jarvis P; Bricaire C
J Steroid Biochem; 1989 Oct; 33(4B):791-4. PubMed ID: 2513454
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
3. Hypothalmic-pituitary relationships in the polycystic ovary syndrome serum gonadotrophin levels following injection of oestradiol benzoate.
Shaw RW; Duignan NM; Butt WR; Edwards RL; London DR
Br J Obstet Gynaecol; 1975 Dec; 82(12):952-7. PubMed ID: 1106757
[TBL] [Abstract][Full Text] [Related]
4. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
6. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
Polson DW; Kiddy DS; Mason HD; Franks S
Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
[TBL] [Abstract][Full Text] [Related]
7. The role of chronic anovulation in the polycystic ovary syndrome: normalization of sex-hormone-binding globulin levels after clomiphene-induced ovulation.
Eden JA; Place J; Carter GD; Alaghband-Zadeh J; Pawson ME
Clin Endocrinol (Oxf); 1989 Mar; 30(3):323-32. PubMed ID: 2512039
[TBL] [Abstract][Full Text] [Related]
8. The role of changing pulse frequency in the regulation of ovulation.
Marshall JC; Griffin ML
Hum Reprod; 1993 Nov; 8 Suppl 2():57-61. PubMed ID: 8276970
[TBL] [Abstract][Full Text] [Related]
9. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
[TBL] [Abstract][Full Text] [Related]
10. Pulsatile luteinizing hormone secretion in women with polycystic ovary syndrome under clomiphene citrate. Differences between responders and nonresponders.
Sir-Petermann T; Alba F; Cohen P; Pacheco J; Devoto L; Rossmanith W
Exp Clin Endocrinol; 1990 Sep; 96(1):45-51. PubMed ID: 2126241
[TBL] [Abstract][Full Text] [Related]
11. Response to clomiphene citrate in the polycystic ovarian syndrome according to different LH/FSH ratios.
Lopez-Lopez E; Noguera MC; Fuente T; Parrilla JJ; Abad L
Hum Reprod; 1987 Nov; 2(8):635-8. PubMed ID: 3125210
[TBL] [Abstract][Full Text] [Related]
12. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
Zaidi J; Jacobs H; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
[TBL] [Abstract][Full Text] [Related]
13. Pituitary gonadotropin-releasing hormone receptor content in rats with polycystic ovaries.
Carriere PD; Brawer JR; Farookhi R
Biol Reprod; 1988 Apr; 38(3):562-7. PubMed ID: 2837294
[TBL] [Abstract][Full Text] [Related]
14. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
Christman GM; Randolph JF; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
[TBL] [Abstract][Full Text] [Related]
15. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Berga SL; Yen SS
Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
[TBL] [Abstract][Full Text] [Related]
16. The androgenic polycystic ovary.
Greenblatt RB; Mahesh VB
Am J Obstet Gynecol; 1976 Jul; 125(5):712-26. PubMed ID: 180807
[TBL] [Abstract][Full Text] [Related]
17. [Relation between hyperprolactinemia and polycystic ovary syndrome].
Hámori M; Szendei G; Kovács I; Somos P
Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
[TBL] [Abstract][Full Text] [Related]
18. [Polycystic ovary syndrome (author's transl)].
Lecomte P; Kuttenn F; Mauvais-Jarvis P
Nouv Presse Med; 1978 Feb; 7(5):355-6, 361-2. PubMed ID: 345233
[TBL] [Abstract][Full Text] [Related]
19. Alterations in gonadotropin-releasing hormone-dependent gonadotropin secretion in rats with polycystic ovaries.
Carrière PD; Brawer JR; Farookhi R
Biol Reprod; 1991 Nov; 45(5):685-90. PubMed ID: 1661616
[TBL] [Abstract][Full Text] [Related]
20. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
